Founded in 1992 in Guangzhou, China, Wondfo Biotech is a leading manufacturer of point-of-care testing (POCT) solutions for the in vitro diagnostics market. With over 3,000 employees, including more than 800 researchers, and a presence in 150+ countries and regions, Wondfo develops rapid, reliable diagnostics across multiple technology platforms: lateral flow (colloidal gold), immunofluorescence, chemiluminescence, coagulation, blood gas, molecular diagnostics, pathology and HPLC hemoglobin testing. Its solutions support clinicians and laboratories in areas such as infectious diseases, cardiovascular and inflammatory markers, fertility, diabetes and critical care.

WEBSITE